Efficacy and safety of mepolizumab in Korean patients with severe eosinophilic asthma from the DREAM and MENSA studies

BACKGROUND/AIMS: The efficacy and safety of mepolizumab in patients with severe eosinophilic asthma has been evaluated in a global clinical trial programme. This post hoc analysis assesses the efficacy and safety of mepolizumab in Korean patients. METHODS: Data from Korean patients in the Phase III,...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Mi-Kyeong, Park, Hae-Sim, Park, Choon-Sik, Min, Soung-Jun, Albers, Frank C., Yancey, Steven W., Mayer, Bhabita, Kwon, Namhee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association of Internal Medicine 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7969054/
https://www.ncbi.nlm.nih.gov/pubmed/32450626
http://dx.doi.org/10.3904/kjim.2019.198

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7969054/
https://www.ncbi.nlm.nih.gov/pubmed/32450626
http://dx.doi.org/10.3904/kjim.2019.198

Ejemplares similares